World's Best Scientists 2026 revealed!
Brenda L. Gallie

Brenda L. Gallie

D-Index & Metrics

Genetics

D-Index
78
Citations
21713
World Ranking
1704
National Ranking
60

Medicine

D-Index
81
Citations
24850
World Ranking
16609
National Ranking
698

Brenda L. Gallie publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Brenda L. Gallie sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 300 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Brenda L. Gallie D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Brenda L. Gallie sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 78 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Brenda L. Gallie is affiliated with the University of Toronto in Canada and has an extensive publication record in the field of medicine, with a strong focus on ophthalmology and oncology. Their research primarily covers ocular oncology, with significant contributions to the study and treatment of retinoblastoma, as well as broader cancer-related molecular pathways and surgical oncology.

The main fields of study for this researcher include:

  • Medicine

Within this broader area, their work specializes in several subfields:

  • Ophthalmology
  • Pulmonary and Respiratory Medicine
  • Oncology
  • Genetics
  • Surgery

Brenda L. Gallie's research topics reflect an emphasis on cancer treatment and diagnostics, including:

  • Ocular Oncology and Treatments
  • Brain Metastases and Treatment
  • Head and Neck Surgical Oncology
  • Nonmelanoma Skin Cancer Studies
  • Cancer-related Molecular Pathways
  • Glioma Diagnosis and Treatment
  • Corneal Surgery and Treatments

Significant recent publications demonstrate ongoing research activity and collaboration across international teams. Selected papers include:

  • A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma (2020, Ophthalmology)
  • Patients presenting with metastases: stage IV uveal melanoma, an international study (2021, British Journal of Ophthalmology)
  • Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma (2020, Ophthalmology Retina)
  • Natural History of Untreated Retinoblastoma (2021, Cancers)
  • Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma (2022, Ophthalmology)

These publications reveal collaborations with frequent co-authors including Zhao Feng, Ashwin Mallipatna, Junyang Zhao, Stephanie N. Kletke, and Furqan Shaikh. The collaboration pattern indicates an active research network within the field of ocular oncology and related disciplines.

Brenda L. Gallie frequently publishes in venues that focus on ophthalmology and cancer research, such as:

  • Cancers
  • Canadian Journal of Ophthalmology
  • Ophthalmology
  • British Journal of Ophthalmology
  • Pediatric Blood & Cancer

Best Publications

  • Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

    W. K. Cavenee;W. K. Cavenee;T. P. Dryja;R. A. Phillips;William F Benedict

  • Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer ☆

    Michael A.S. Jewett;Kamal Mattar;Joan Basiuk;Christopher G. Morash

  • Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition

    Marc F. Hansen;Alex Koufos;Brenda L. Gallie;Robert A. Phillips

  • Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma

    Michael D. Onken;Lori A. Worley;Devron H. Char;James J. Augsburger

  • Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy

    Brenda L. Gallie;Andrew Budning;Gerrit DeBoer;Jake J. Thiessen

  • Genetic origin of mutations predisposing to retinoblastoma.

    Webster K. Cavenee;Marc F. Hansen;Magnus Nordenskjold;Eric Kock

  • Using expression profiling data to identify human microRNA targets.

    Jim C Huang;Tomas Babak;Timothy W Corson;Timothy W Corson;Timothy W Corson;Gordon Chua

  • Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.

    Diane E Rushlow;Berber M Mol;Jennifer Y Kennett;Stephanie Yee;Stephanie Yee

  • pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis.

    E Zacksenhaus;Z Jiang;D Chung;J D Marth

  • Identification of germline and somatic mutations affecting the retinoblastoma gene.

    James M. Dunn;Robert A. Phillips;Andrew J. Becker;Brenda L. Gallie

  • Sensitive and Efficient Detection of RB1 Gene Mutations Enhances Care for Families with Retinoblastoma

    Suzanne Richter;Kirk Vandezande;Ning Chen;Katherine Zhang

  • Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma

    Helen Dimaras;Helen Dimaras;Vikas Khetan;William Halliday;Marija Orlic;Marija Orlic

  • Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

    P A Hamel;R M Gill;R A Phillips;B L Gallie

  • Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma.

    R. Godbout;R. Godbout;T. P. Dryja;J. Squire;B. L. Gallie;B. L. Gallie

  • One Hit, Two Hits, Three Hits, More? Genomic Changes in the Development of Retinoblastoma

    Timothy W. Corson;Brenda L. Gallie

  • Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

    B L Gallie;R M Ellsworth;D H Abramson;R A Phillips

  • The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma

    E. Rand Simpson;Brenda Gallie;Normand Laperrierre;Akbar Beiki-Ardakani

  • Global Retinoblastoma Presentation and Analysis by National Income Level

    Ido Didi Fabian;Ido Didi Fabian;Elhassan Abdallah;Shehu U. Abdullahi;Rula A. Abdulqader

  • Direct transcriptional repression by pRB and its reversal by specific cyclins.

    R Bremner;B L Cohen;M Sopta;P A Hamel

  • Retinoblastoma: revisiting the model prototype of inherited cancer.

    Dietmar R. Lohmann;Brenda L. Gallie

Frequent Co-Authors

Elise Héon
Elise Héon University of Toronto
Robert A. Phillips
Robert A. Phillips University of Toronto
Jeremy A. Squire
Jeremy A. Squire Universidade de São Paulo
Michael A.S. Jewett
Michael A.S. Jewett University of Toronto
Antonio Finelli
Antonio Finelli University Health Network
Victor Ling
Victor Ling BC Cancer Research Centre
Roseline Godbout
Roseline Godbout University of Alberta
Thaddeus P. Dryja
Thaddeus P. Dryja Massachusetts Eye and Ear Infirmary
Neil Fleshner
Neil Fleshner Princess Margaret Cancer Centre
Rod Bremner
Rod Bremner Lunenfeld-Tanenbaum Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re fascinated by Genetics but interested in alternative career paths, there are several related online programs to consider. For example, online medical coding programs offer a practical entry into healthcare, focusing on crucial behind-the-scenes roles that connect clinical practice with healthcare administration.

Students seeking a faster route to a degree may be interested in fast track schools, which allow you to complete your studies in a shorter time frame. These programs are ideal for motivated learners eager to launch their careers quickly.

Flexibility is also a key consideration. Self paced degrees allow you to study at your own speed, making it easier to balance education with work or family commitments.

Additionally, finding online colleges free application can save you money during the admissions process, removing unnecessary barriers for prospective students.

Best Scientists Citing Brenda L. Gallie

Trending Scientists

Recently Published Articles